http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105622480-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_372338508c8646c4a6e59b6be42ccb56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-452
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-452
filingDate 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_703f477f5a2b63ed58314942d5e98b83
publicationDate 2016-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105622480-A
titleOfInvention Synthetic method for furan diamine drug intermediate N-(2-ethoxyl) phthalimide
abstract The invention relates to a synthetic method for furan diamine drug intermediate N-(2-ethoxyl) phthalimide. The synthetic method includes the following steps that 0.43 mol of phthalic anhydride, 0.05 mol of cuprous chloride, 300 ml of pyridine and 0.44-0.46 mol of ethanol hydroxylamine are added into a reaction vessel provided with a stirrer, a thermometer and a reflux condenser, the solution temperature is slowly raised, a reflux reaction is conducted for 3-4 h at the temperature of 205 DEG C-215 DEG C, the solution temperature is reduced to 10 DEG C-minus 15 DEG C to separate a solid, the solid is added into 500 ml of a xylene solution, the solution temperature is reduced to 3 DEG C-minus 5 DEG C to separate a solid, the solid is sequentially washed with a salt solution, dehydrated with a dehydrating agent and recrystallized in ethyl acetate to obtain a white solid N-(2-ethoxyl) phthalimide. In the steps, the mass fraction of pyridine is 85-90%, and the mass fraction of the xylene solution is 55-60%.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106632444-A
priorityDate 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22336849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451577746
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID469715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID253877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451816491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62652
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159940
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449731539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450438466
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411286125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21989049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455621757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415973668

Total number of triples: 47.